+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Insulin Market Research Report by Drug (Biologic and Biosimilar), Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 254 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 5337609
UP TO OFF until Dec 31st 2022
The Global Insulin Market size was estimated at USD 36.16 billion in 2021, USD 40.82 billion in 2022, and is projected to grow at a CAGR 13.08% to reach USD 75.62 billion by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Insulin to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Drug, the market was studied across Biologic and Biosimilar.
  • Based on Application, the market was studied across Type I Diabetes and Type II Diabetes.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Insulin market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Insulin Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Insulin Market, including Adocia, AstraZeneca PLC, B. Braun Melsungen AG, Becton, Dickinson and Company, Biocon Limited, Biodel Inc., Bioton SA, Dongbao Enterprise Group Co., Ltd., Eli Lilly and Company, GLAXOSMITHKLINE PLC, Johnson & Johnson, Julphar, MannKind Corporation, Medtronic PLC, Merck & Co., Novartis International AG, Novo Nordisk A/S, Oramed Pharmaceuticals, Pfizer Inc., Piramal Healthcare, Sanofi SA, Teijin Limited, Tonghua Dongbao Pharmaceutical Co., Ltd, US Vitamins Limited, Wockhardt Ltd, and Ypsomed AG.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Insulin Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Insulin Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Insulin Market?
4. What is the competitive strategic window for opportunities in the Global Insulin Market?
5. What are the technology trends and regulatory frameworks in the Global Insulin Market?
6. What is the market share of the leading vendors in the Global Insulin Market?
7. What modes and strategic moves are considered suitable for entering the Global Insulin Market?
Frequently Asked Questions about the Global Insulin Market

What is the estimated value of the Global Insulin Market?

The Global Insulin Market was estimated to be valued at $36.16 Billion in 2021.

What is the growth rate of the Global Insulin Market?

The growth rate of the Global Insulin Market is 13.0%, with an estimated value of $75.62 Billion by 2027.

What is the forecasted size of the Global Insulin Market?

The Global Insulin Market is estimated to be worth $75.62 Billion by 2027.

Who are the key companies in the Global Insulin Market?

Key companies in the Global Insulin Market include Adocia, AstraZeneca PLC, B. Braun Melsungen AG, Becton, Dickinson and Company, Biocon Limited, Biodel Inc., Bioton SA, Dongbao Enterprise Group Co., Ltd. and GLAXOSMITHKLINE PLC.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of diabetes among the population
5.1.1.2. Increasing incidence of geriatric and obese population
5.1.1.3. Rapid development in insulin delivery systems, drug, and analog development
5.1.2. Restraints
5.1.2.1. High cost associated with insulin drugs
5.1.3. Opportunities
5.1.3.1. New regulations for insulin biosimilars and rising investments in R&D
5.1.3.2. High potential of insulin drug in emerging economies
5.1.4. Challenges
5.1.4.1. Strict regulatory norms for the approval of product
5.2. Cumulative Impact of COVID-19
6. Insulin Market, by Drug
6.1. Introduction
6.2. Biologic
6.3. Biosimilar
7. Insulin Market, by Application
7.1. Introduction
7.2. Type I Diabetes
7.3. Type II Diabetes
8. Americas Insulin Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Insulin Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
10. Europe, Middle East & Africa Insulin Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. Adocia
12.2. AstraZeneca PLC
12.3. B. Braun Melsungen AG
12.4. Becton, Dickinson and Company
12.5. Biocon Limited
12.6. Biodel Inc.
12.7. Bioton SA
12.8. Dongbao Enterprise Group Co., Ltd.
12.9. Eli Lilly and Company
12.10. GLAXOSMITHKLINE PLC
12.11. Johnson & Johnson
12.12. Julphar
12.13. MannKind Corporation
12.14. Medtronic PLC
12.15. Merck & Co.
12.16. Novartis International AG
12.17. Novo Nordisk A/S
12.18. Oramed Pharmaceuticals
12.19. Pfizer Inc.
12.20. Piramal Healthcare
12.21. Sanofi SA
12.22. Teijin Limited
12.23. Tonghua Dongbao Pharmaceutical Co., Ltd
12.24. US Vitamins Limited
12.25. Wockhardt Ltd
12.26. Ypsomed AG
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL INSULIN MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL INSULIN MARKET SIZE, 2021 VS 2027 (USD BILLION)
FIGURE 3. GLOBAL INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 4. GLOBAL INSULIN MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL INSULIN MARKET SIZE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INSULIN MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL INSULIN MARKET DYNAMICS
FIGURE 8. GLOBAL INSULIN MARKET SIZE, BY DRUG, 2021 VS 2027 (%)
FIGURE 9. GLOBAL INSULIN MARKET SIZE, BY DRUG, 2021 VS 2027 (USD BILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INSULIN MARKET SIZE, BY DRUG, 2027
FIGURE 11. GLOBAL INSULIN MARKET SIZE, BY BIOLOGIC, 2019-2027 (USD BILLION)
FIGURE 12. GLOBAL INSULIN MARKET SIZE, BY BIOLOGIC, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 13. GLOBAL INSULIN MARKET SIZE, BY BIOSIMILAR, 2019-2027 (USD BILLION)
FIGURE 14. GLOBAL INSULIN MARKET SIZE, BY BIOSIMILAR, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 15. GLOBAL INSULIN MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 16. GLOBAL INSULIN MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD BILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INSULIN MARKET SIZE, BY APPLICATION, 2027
FIGURE 18. GLOBAL INSULIN MARKET SIZE, BY TYPE I DIABETES, 2019-2027 (USD BILLION)
FIGURE 19. GLOBAL INSULIN MARKET SIZE, BY TYPE I DIABETES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 20. GLOBAL INSULIN MARKET SIZE, BY TYPE II DIABETES, 2019-2027 (USD BILLION)
FIGURE 21. GLOBAL INSULIN MARKET SIZE, BY TYPE II DIABETES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 22. AMERICAS INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 23. AMERICAS INSULIN MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 24. AMERICAS INSULIN MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 25. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS INSULIN MARKET SIZE, BY COUNTRY, 2027
FIGURE 26. ARGENTINA INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 27. BRAZIL INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 28. CANADA INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 29. MEXICO INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 30. UNITED STATES INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 31. UNITED STATES INSULIN MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 32. UNITED STATES INSULIN MARKET SIZE, BY STATE, 2021 VS 2027 (USD BILLION)
FIGURE 33. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES INSULIN MARKET SIZE, BY STATE, 2027
FIGURE 34. ASIA-PACIFIC INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 35. ASIA-PACIFIC INSULIN MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 36. ASIA-PACIFIC INSULIN MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC INSULIN MARKET SIZE, BY COUNTRY, 2027
FIGURE 38. AUSTRALIA INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 39. CHINA INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 40. INDIA INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 41. INDONESIA INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 42. JAPAN INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 43. MALAYSIA INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 44. PHILIPPINES INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 45. SINGAPORE INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 46. SOUTH KOREA INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 47. TAIWAN INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 48. THAILAND INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 49. EUROPE, MIDDLE EAST & AFRICA INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 50. EUROPE, MIDDLE EAST & AFRICA INSULIN MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 51. EUROPE, MIDDLE EAST & AFRICA INSULIN MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 52. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA INSULIN MARKET SIZE, BY COUNTRY, 2027
FIGURE 53. FRANCE INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 54. GERMANY INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 55. ITALY INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 56. NETHERLANDS INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 57. QATAR INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 58. RUSSIA INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 59. SAUDI ARABIA INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 60. SOUTH AFRICA INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 61. SPAIN INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 62. UNITED ARAB EMIRATES INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 63. UNITED KINGDOM INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 64. GLOBAL INSULIN MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 65. GLOBAL INSULIN MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 66. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL INSULIN MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL INSULIN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 4. GLOBAL INSULIN MARKET SIZE, BY REGION, 2019-2027 (USD BILLION)
TABLE 5. GLOBAL INSULIN MARKET SIZE, BY DRUG, 2019-2027 (USD BILLION)
TABLE 6. GLOBAL INSULIN MARKET SIZE, BY BIOLOGIC, BY REGION, 2019-2027 (USD BILLION)
TABLE 7. AMERICAS INSULIN MARKET SIZE, BY BIOLOGIC, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 8. UNITED STATES INSULIN MARKET SIZE, BY BIOLOGIC, BY STATE, 2019-2027 (USD BILLION)
TABLE 9. ASIA-PACIFIC INSULIN MARKET SIZE, BY BIOLOGIC, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA INSULIN MARKET SIZE, BY BIOLOGIC, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 11. GLOBAL INSULIN MARKET SIZE, BY BIOSIMILAR, BY REGION, 2019-2027 (USD BILLION)
TABLE 12. AMERICAS INSULIN MARKET SIZE, BY BIOSIMILAR, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 13. UNITED STATES INSULIN MARKET SIZE, BY BIOSIMILAR, BY STATE, 2019-2027 (USD BILLION)
TABLE 14. ASIA-PACIFIC INSULIN MARKET SIZE, BY BIOSIMILAR, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA INSULIN MARKET SIZE, BY BIOSIMILAR, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 16. GLOBAL INSULIN MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 17. GLOBAL INSULIN MARKET SIZE, BY TYPE I DIABETES, BY REGION, 2019-2027 (USD BILLION)
TABLE 18. AMERICAS INSULIN MARKET SIZE, BY TYPE I DIABETES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 19. UNITED STATES INSULIN MARKET SIZE, BY TYPE I DIABETES, BY STATE, 2019-2027 (USD BILLION)
TABLE 20. ASIA-PACIFIC INSULIN MARKET SIZE, BY TYPE I DIABETES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 21. EUROPE, MIDDLE EAST & AFRICA INSULIN MARKET SIZE, BY TYPE I DIABETES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 22. GLOBAL INSULIN MARKET SIZE, BY TYPE II DIABETES, BY REGION, 2019-2027 (USD BILLION)
TABLE 23. AMERICAS INSULIN MARKET SIZE, BY TYPE II DIABETES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 24. UNITED STATES INSULIN MARKET SIZE, BY TYPE II DIABETES, BY STATE, 2019-2027 (USD BILLION)
TABLE 25. ASIA-PACIFIC INSULIN MARKET SIZE, BY TYPE II DIABETES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 26. EUROPE, MIDDLE EAST & AFRICA INSULIN MARKET SIZE, BY TYPE II DIABETES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 27. AMERICAS INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 28. AMERICAS INSULIN MARKET SIZE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 29. AMERICAS INSULIN MARKET SIZE, BY DRUG, 2019-2027 (USD BILLION)
TABLE 30. AMERICAS INSULIN MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 31. ARGENTINA INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 32. ARGENTINA INSULIN MARKET SIZE, BY DRUG, 2019-2027 (USD BILLION)
TABLE 33. ARGENTINA INSULIN MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 34. BRAZIL INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 35. BRAZIL INSULIN MARKET SIZE, BY DRUG, 2019-2027 (USD BILLION)
TABLE 36. BRAZIL INSULIN MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 37. CANADA INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 38. CANADA INSULIN MARKET SIZE, BY DRUG, 2019-2027 (USD BILLION)
TABLE 39. CANADA INSULIN MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 40. MEXICO INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 41. MEXICO INSULIN MARKET SIZE, BY DRUG, 2019-2027 (USD BILLION)
TABLE 42. MEXICO INSULIN MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 43. UNITED STATES INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 44. UNITED STATES INSULIN MARKET SIZE, BY STATE, 2019-2027 (USD BILLION)
TABLE 45. UNITED STATES INSULIN MARKET SIZE, BY DRUG, 2019-2027 (USD BILLION)
TABLE 46. UNITED STATES INSULIN MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 47. ASIA-PACIFIC INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 48. ASIA-PACIFIC INSULIN MARKET SIZE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 49. ASIA-PACIFIC INSULIN MARKET SIZE, BY DRUG, 2019-2027 (USD BILLION)
TABLE 50. ASIA-PACIFIC INSULIN MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 51. AUSTRALIA INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 52. AUSTRALIA INSULIN MARKET SIZE, BY DRUG, 2019-2027 (USD BILLION)
TABLE 53. AUSTRALIA INSULIN MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 54. CHINA INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 55. CHINA INSULIN MARKET SIZE, BY DRUG, 2019-2027 (USD BILLION)
TABLE 56. CHINA INSULIN MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 57. INDIA INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 58. INDIA INSULIN MARKET SIZE, BY DRUG, 2019-2027 (USD BILLION)
TABLE 59. INDIA INSULIN MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 60. INDONESIA INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 61. INDONESIA INSULIN MARKET SIZE, BY DRUG, 2019-2027 (USD BILLION)
TABLE 62. INDONESIA INSULIN MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 63. JAPAN INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 64. JAPAN INSULIN MARKET SIZE, BY DRUG, 2019-2027 (USD BILLION)
TABLE 65. JAPAN INSULIN MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 66. MALAYSIA INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 67. MALAYSIA INSULIN MARKET SIZE, BY DRUG, 2019-2027 (USD BILLION)
TABLE 68. MALAYSIA INSULIN MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 69. PHILIPPINES INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 70. PHILIPPINES INSULIN MARKET SIZE, BY DRUG, 2019-2027 (USD BILLION)
TABLE 71. PHILIPPINES INSULIN MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 72. SINGAPORE INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 73. SINGAPORE INSULIN MARKET SIZE, BY DRUG, 2019-2027 (USD BILLION)
TABLE 74. SINGAPORE INSULIN MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 75. SOUTH KOREA INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 76. SOUTH KOREA INSULIN MARKET SIZE, BY DRUG, 2019-2027 (USD BILLION)
TABLE 77. SOUTH KOREA INSULIN MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 78. TAIWAN INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 79. TAIWAN INSULIN MARKET SIZE, BY DRUG, 2019-2027 (USD BILLION)
TABLE 80. TAIWAN INSULIN MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 81. THAILAND INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 82. THAILAND INSULIN MARKET SIZE, BY DRUG, 2019-2027 (USD BILLION)
TABLE 83. THAILAND INSULIN MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA INSULIN MARKET SIZE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA INSULIN MARKET SIZE, BY DRUG, 2019-2027 (USD BILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA INSULIN MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 88. FRANCE INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 89. FRANCE INSULIN MARKET SIZE, BY DRUG, 2019-2027 (USD BILLION)
TABLE 90. FRANCE INSULIN MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 91. GERMANY INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 92. GERMANY INSULIN MARKET SIZE, BY DRUG, 2019-2027 (USD BILLION)
TABLE 93. GERMANY INSULIN MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 94. ITALY INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 95. ITALY INSULIN MARKET SIZE, BY DRUG, 2019-2027 (USD BILLION)
TABLE 96. ITALY INSULIN MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 97. NETHERLANDS INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 98. NETHERLANDS INSULIN MARKET SIZE, BY DRUG, 2019-2027 (USD BILLION)
TABLE 99. NETHERLANDS INSULIN MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 100. QATAR INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 101. QATAR INSULIN MARKET SIZE, BY DRUG, 2019-2027 (USD BILLION)
TABLE 102. QATAR INSULIN MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 103. RUSSIA INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 104. RUSSIA INSULIN MARKET SIZE, BY DRUG, 2019-2027 (USD BILLION)
TABLE 105. RUSSIA INSULIN MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 106. SAUDI ARABIA INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 107. SAUDI ARABIA INSULIN MARKET SIZE, BY DRUG, 2019-2027 (USD BILLION)
TABLE 108. SAUDI ARABIA INSULIN MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 109. SOUTH AFRICA INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 110. SOUTH AFRICA INSULIN MARKET SIZE, BY DRUG, 2019-2027 (USD BILLION)
TABLE 111. SOUTH AFRICA INSULIN MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 112. SPAIN INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 113. SPAIN INSULIN MARKET SIZE, BY DRUG, 2019-2027 (USD BILLION)
TABLE 114. SPAIN INSULIN MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 115. UNITED ARAB EMIRATES INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 116. UNITED ARAB EMIRATES INSULIN MARKET SIZE, BY DRUG, 2019-2027 (USD BILLION)
TABLE 117. UNITED ARAB EMIRATES INSULIN MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 118. UNITED KINGDOM INSULIN MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 119. UNITED KINGDOM INSULIN MARKET SIZE, BY DRUG, 2019-2027 (USD BILLION)
TABLE 120. UNITED KINGDOM INSULIN MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 121. GLOBAL INSULIN MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 122. GLOBAL INSULIN MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 123. GLOBAL INSULIN MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 124. GLOBAL INSULIN MARKET RANKING
TABLE 125. GLOBAL INSULIN MARKET SHARE, BY KEY PLAYER, 2021
TABLE 126. GLOBAL INSULIN MARKET MERGER & ACQUISITION
TABLE 127. GLOBAL INSULIN MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 128. GLOBAL INSULIN MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 129. GLOBAL INSULIN MARKET INVESTMENT & FUNDING
TABLE 130. GLOBAL INSULIN MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 131. GLOBAL INSULIN MARKET: LICENSE & PRICING

Companies Mentioned

  • Adocia
  • AstraZeneca PLC
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Biocon Limited
  • Biodel Inc.
  • Bioton SA
  • Dongbao Enterprise Group Co., Ltd.
  • Eli Lilly and Company
  • GLAXOSMITHKLINE PLC
  • Johnson & Johnson
  • Julphar
  • MannKind Corporation
  • Medtronic PLC
  • Merck & Co.
  • Novartis International AG
  • Novo Nordisk A/S
  • Oramed Pharmaceuticals
  • Pfizer Inc.
  • Piramal Healthcare
  • Sanofi SA
  • Teijin Limited
  • Tonghua Dongbao Pharmaceutical Co., Ltd
  • US Vitamins Limited
  • Wockhardt Ltd
  • Ypsomed AG

Methodology

Loading
LOADING...